BNTC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Benitec Biopharma Inc (BNTC) is not a strong buy for a beginner, long-term investor at this time. The stock lacks significant positive catalysts, has weak financial performance, and no clear technical or proprietary trading signals to suggest immediate upside potential. Given the user's preference for long-term investment, it is better to hold off on investing until stronger growth trends or positive signals emerge.
The MACD is positive but contracting, RSI is neutral at 47.342, and moving averages are converging, indicating no clear trend. The stock is trading below its pivot level of 12.818, with support at 11.569 and resistance at 14.067. Overall, the technical indicators do not suggest a strong buy signal.
Hedge funds are significantly increasing their positions, with a 599.83% increase in buying activity over the last quarter.
No recent news or event-driven catalysts. Insiders are neutral with no significant trading activity. The stock has a 70% chance of a -2.78% decline in the next week.
In Q2 2026, revenue remained at 0 with no growth. Net income improved by 23.92% YoY but remains negative at -11.84 million. EPS is stagnant at -0.26. Gross margin is 0, reflecting weak financial health.
No recent analyst ratings or price target updates are available for BNTC.
